References and Notes
<A NAME="RG34009ST-1A">1a</A>
Fluorine in Bioorganic Chemistry
Filler R.
Kobayasi Y.
Yagupolskii LM.
Elsevier;
Amsterdam:
1993.
<A NAME="RG34009ST-1B">1b</A>
Filler R.
Fluorine Containing Drugs in Organofluorine Chemicals
and their Industrial Application
Pergamon;
New York:
1979.
Chap.
6.
<A NAME="RG34009ST-1C">1c</A>
Hudlicky M.
Chemistry of Organic Compounds
Ellis
Horwood;
Chichester:
1992.
<A NAME="RG34009ST-1D">1d</A>
Kirsch P.
Modern Fluoroorganic Chemistry
Wiley-VCH;
Weinheim:
2004.
<A NAME="RG34009ST-1E">1e</A>
Chambers RD.
Fluorine in Organic Chemistry
Blackwell
Publishing CRC Press;
Florida:
2004.
See also:
<A NAME="RG34009ST-1F">1f</A>
Ryckmanns T.
Balancon L.
Berton O.
Genicot C.
Lamberty Y.
Lallemand B.
Passau P.
Pirlot N.
Quéré L.
Talaga P.
Bioorg. Med. Chem. Lett.
2002,
12:
261
<A NAME="RG34009ST-1G">1g</A>
Malamas MS.
Sredy J.
Moxham C.
Katz A.
Xu W.
McDevitt R.
Adebayo
FO.
Sawicki DR.
Seestaller L.
Sullivan D.
Taylor
JR.
J. Med. Chem.
2000,
43:
1293
<A NAME="RG34009ST-1H">1h</A>
Ciha AJ.
Ruminski PG.
J.
Agric. Food Chem.
1991,
39:
2072
<A NAME="RG34009ST-1I">1i</A>
Albrecht HA.
Beskid G.
Georgopapadakou NH.
Keith DD.
Konzelmann FM.
Pruess DL.
Rossman
PL.
Wei CC.
Christenson JG.
J. Med. Chem.
1991,
34:
2857
<A NAME="RG34009ST-1J">1j</A>
Albrecht HA.
Beskid G.
Christenson JG.
Deitcher KH.
Georgopapadakou NH.
Keith DD.
Konzelmann FM.
Pruess DL.
Wie CC.
J.
Med. Chem.
1994,
37:
400
<A NAME="RG34009ST-1K">1k</A>
Song CW.
Lee KY.
Kim CD.
Chang T.-M.
Chey WY.
J. Pharmacol. Exp. Ther.
1997,
281:
1312
<A NAME="RG34009ST-1L">1l</A>
De Voss JJ.
Sui Z.
DeCamp DL.
Salto R.
Babe LM.
Craik CS.
Ortiz de Montellano PR.
J. Med. Chem.
1994,
37:
665
<A NAME="RG34009ST-1M">1m</A>
Anjaiah S.
Chandrasekhar S.
Gree R.
Adv.
Synth. Catal.
2004,
346:
1329
<A NAME="RG34009ST-1N">1n</A>
Iorio MA.
Paszkowska RT.
Frigeni V.
J. Med. Chem.
1987,
30:
1906
<A NAME="RG34009ST-1O">1o</A>
Popp JL.
Musza LL.
Barrow CJ.
Rudewicz PJ.
Houck DR.
J. Antibiot.
1994,
47:
411
<A NAME="RG34009ST-1P">1p</A>
Chen TS.
Petuch B.
MacConnell J.
White R.
Dezeny G.
J.
Antibiot.
1994,
47:
1290
<A NAME="RG34009ST-1Q">1q</A>
Lam KS.
Schroeder DR.
Veitch JMJM.
Colson KL.
Matson JA.
Rose WC.
Doyle TW.
Forenza S.
J.
Antibiot.
2001,
54:
1
<A NAME="RG34009ST-2">2</A>
Metal-Catalyzed
Cross-Coupling Reactions
de Meijere A.
Diederich F.
Wiley-VCH;
Weinheim:
2004.
Reviews:
<A NAME="RG34009ST-3A">3a</A>
Wittkopp A.
Schreiner PR.
The
Chemistry of Dienes and Polyenes
Vol. 2:
John
Wiley & Sons Ltd.;
New York:
2000.
<A NAME="RG34009ST-3B">3b</A>
Schreiner PR.
Chem. Soc. Rev.
2003,
32:
289
See also:
<A NAME="RG34009ST-3C">3c</A>
Wittkopp A.
Schreiner PR.
Chem. Eur. J.
2003,
9:
407
<A NAME="RG34009ST-3D">3d</A>
Kleiner CM.
Schreiner PR.
Chem.
Commun.
2006,
4315
<A NAME="RG34009ST-3E">3e</A>
Kotke M.
Schreiner PR.
Synthesis
2007,
779
<A NAME="RG34009ST-3F">3f</A> Review:
Tsogoeva SB.
Eur. J. Org. Chem.
2007,
1701
<A NAME="RG34009ST-4A">4a</A>
Schmidbaur H.
Kumberger O.
Chem.
Ber.
1993,
126:
3
<A NAME="RG34009ST-4B">4b</A>
Dinger MB.
Henderson W.
J. Organomet.
Chem.
1998,
560:
233
<A NAME="RG34009ST-4C">4c</A>
Liedtke J.
Loss S.
Widauer C.
Grützmacher H.
Tetrahedron
2000,
56:
143
<A NAME="RG34009ST-4D">4d</A>
Schneider S.
Tzschucke CC.
Bannwarth W.
Multiphase Homogeneous Catalysis
Cornils B.
Herrmann WA.
Horvath IT.
Leitner W.
Mecking S.
Olivier-Booubigou H.
Vogt D.
Wiley-VCH;
Weinheim:
2005.
Chap.
4.
p.346
<A NAME="RG34009ST-4E">4e</A>
Clarke D.
Ali MA.
Clifford AA.
Parratt A.
Rose P.
Schwinn D.
Bannwarth W.
Rayner CM.
Curr. Top. Med. Chem.
2004,
7:
729
<A NAME="RG34009ST-5A">5a</A>
Shi G.-Q.
Cottens S.
Shiba SA.
Schlosser MA.
Tetrahedron
1992,
48:
10569
<A NAME="RG34009ST-5B">5b</A>
Shi G.-Q.
Schlosser M.
Tetrahedron
1993,
49:
1445
<A NAME="RG34009ST-5C">5c</A>
Patrick TB.
Rogers J.
Gorrell K.
Org. Lett.
2002,
4:
3155
<A NAME="RG34009ST-6">6</A>
Lefebvre O.
Brigaud T.
Portella C.
Tetrahedron
1998,
54:
5939
<A NAME="RG34009ST-7">7</A> For a review of 1,3-bis(silyloxy)-1,3-butadienes
in general, see:
Langer P.
Synthesis
2002,
441
<A NAME="RG34009ST-8">8</A> For a review of [3+3] cyclizations,
see:
Feist H.
Langer P.
Synthesis
2007,
327
<A NAME="RG34009ST-9A">9a</A>
Adeel M.
Reim S.
Wolf V.
Yawer MA.
Hussain I.
Villinger A.
Langer P.
Synlett
2008,
2629
<A NAME="RG34009ST-9B">9b</A>
Hussain I.
Yawer MA.
Lau M.
Pundt T.
Fischer C.
Reinke H.
Görls H.
Langer P.
Eur. J. Org. Chem.
2008,
503
<A NAME="RG34009ST-10">10</A> For reviews of site-selective palladium(0)-catalyzed
cross-coupling reactions of polyhalogenated substrates, see:
Schröter S.
Stock C.
Bach T.
Tetrahedron
2005,
61:
2245
<A NAME="RG34009ST-11">11</A>
Synthesis of Dimethyl
4-Fluoro-3,5-dihydroxyphthalate (2): Diene 1 (9.0
g, 30.8 mmol) was added to DMAD (6.5 g, 5.5 mL, 46.2
mmol) at -78 ˚C. The mixture(neat) was allowed
to warm to 20 ˚C during 20 h with stirring. To the mixture
were added hydrochloric acid (10%) and dichloromethane
(50 mL each). The organic and the aqueous layer were separated and
the latter was extracted with CH2Cl2. The
combined organic layers were dried (Na2SO4), filtered
and the filtrate was concentrated in vacuo. The residue was purified
by column chromatography to give 2 as a
crystalline colorless solid (3.0 g, 40%); mp 140-142 ˚C. ¹H NMR
(250 MHz, CDCl3): δ = 3.87 (s, 3 H,
OMe), 3.90 (s, 3 H, OMe), 6.15 (s, 1 H, OH), 6.60 (d, 1 H, J
FH = 7.5 Hz, ArH), 10.96
(s, 1 H, OH). ¹³C NMR (75 MHz, CDCl3): δ = 52.8 (OMe),
53.0 (OMe), 104.6 (C), 108.4 (CH), 131.6 (d, J
FC = 4.5
Hz, C), 140.5 (d, J
FC = 239
Hz, CF), 148.3 (d, J
FC = 11.7 Hz,
COH), 151.1 (d, J
FC = 11.0
Hz, COH), 168.6 (C=O), 168.8 (d, J
FC = 3.0
Hz, C=O). ¹9F NMR (282 MHz, CDCl3): δ = -160.80
(F). IR (ATR): 3292 (m), 2962 (w), 2859 (w), 1716 (s), 1682 (s),
1621 (s), 1599 (s), 1515 (w), 1434 (s), 1325 (s), 1236 (s), 1093
(s), 933 (w) cm-¹. GC-MS (EI,
70 eV): m/z (%) = 244
(24) [M+], 212 (53), 181 (11),
154 (100), 137 (4), 126 (12), 97 (9). HRMS (EI): m/z [M+] calcd
for C10H9O6F: 244.03777; found:
244.037617.
<A NAME="RG34009ST-12">12</A>
Dimethyl 4-Fluoro-3,5-bis(trifluoromethylsulfonyloxy)-phthalate
(3): To a solution of 2 (1.0 equiv)
in CH2Cl2 (10 mL/mmol) was added
pyridine (4.0 equiv) at - 78 ˚C under an argon
atmosphere. After 10 min, Tf2O (2.4 equiv) was added
at -78 ˚C. The mixture was allowed to warm up
to 0 ˚C and stirred for 4 h. The reaction mixture was filtered
and the filtrate was concentrated in vacuo. The products of the reaction
mixture were isolated by rapid column chromatography (flash silica
gel, heptanes-EtOAc). Starting with 2 (2.00
g, 8.0 mmol), pyridine (2.6 mL, 32.0 mmol), CH2Cl2 (80
mL), Tf2O (3.2 mL, 19.2 mmol), 3 was
isolated as a viscous colorless liquid (3.54 g, 87%). ¹H
NMR (300 MHz, CDCl3): δ = 3.87 (s,
3 H, OMe), 3.90 (s, 3 H, OMe), 7.96 (d, 4
J
FH = 6.4 Hz, 1 H,
ArH). ¹³C NMR (75 MHz, CDCl3): δ = 52.6
(OMe), 52.7 (OMe), 117.5 (q, ¹
J
CF = 321 Hz,
CF3), 117.6 (q, ¹
J
CF = 321
Hz, CF3), 124.3 (br s, CH), 124.9 (d, ³
J
FC = 5.0 Hz, C),
130.9 (C), 133.8 (d, ²
J
FC = 13.2 Hz,
C), 136.7 (d, ²
J = 12.2
Hz, C), 148.0 (d, ¹
J = 268
Hz, CF), 161 (CO), 161.4 (d, 4
J
FC = 1.6
Hz, CO). ¹9F NMR (282 MHz, CDCl3): δ = 129.34, -72.81 (d, 5
J
FCF3 = 5.1 Hz, CF3), -72.51 (d, 5
J
FCF3 = 14.31 Hz,
CF3). IR (ATR): 2960 (w), 2922 (w), 1739 (s), 1616 (w),
1595 (w), 1502 (w), 1426 (s), 1326 (m), 1209 (s), 1128 (m), 1045
(m), 1011 (s), 971 (s), 887 (m), 821 (m), 787 (s), 750 (m), 736
(m), 650 (w), 601 (s) cm-¹. GC-MS
(70 eV): m/z (%) = 510
(1) [M+ + 2], 509
(2) [M+ + 1], 508
(12) [M+], 477 (100), 439
(5), 413 (44), 349 (52), 283 (33), 253 (6), 222 (19), 183 (16),
155 (14), 127 (4), 81 (8), 69 (63), 59 (15), 45 (4). HRMS (EI): m/z [M+] calcd
for C12H7O10F7S2:
507.93634; found: 507.936470.
<A NAME="RG34009ST-13">13</A>
CCDC 753087 and CCDC 753088 contain
the supplementary crystallographic data for this paper. These data
can be obtained free of charge from The Cambridge Crystallographic
Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
<A NAME="RG34009ST-14">14</A>
General Procedure
for Suzuki-Miyaura Reactions:
A 1,4-dioxane
solution (4 mL per 3 mmol of 3
) of 3, K3PO4, Pd(PPh3)4 and
arylboronic acid 4 was stirred at 110 ˚C
or 90 ˚C for 8 h. After cooling to 20 ˚C, a saturated
aqueous solution of NH4Cl was added. The organic and
the aqueous layers were separated and the latter was extracted with CH2Cl2.
The combined organic layers were dried (Na2SO4), filtered
and the filtrate was concentrated in vacuo. The residue was purified
by column chromatography.
<A NAME="RG34009ST-15">15</A>
Dimethyl 4-Fluoro-3,5-di(4-ethylphenyl)phthalate
(5e): Starting with 3 (152 mg, 0.3
mmol), K3PO4 (191 mg, 0.9 mmol), Pd(PPh3)4 (3
mol%), 4-ethylphenylboronic acid (105 mg, 0.7 mmol) and
1,4-dioxane (4 mL), 5e was isolated as
a colorless solid (91 mg, 72%); mp 151-153 ˚C. ¹H
NMR (300 MHz, CDCl3): δ = 1.19 (t, J = 7.5 Hz, 3 H, Me), 1.20 (t, J = 7.5 Hz, 3 H, Me), 2.62 (q, J = 7.6 Hz, 2 H, CH2),
2.63 (q,
J = 7.6 Hz,
2 H, CH2), 3.56 (s, 3 H, OMe), 3.83 (s, 3 H, OMe), 7.16-7.23
(m, 9 H, ArH). ¹³C NMR (75 MHz, CDCl3):
δ = 15.3,
15.5 (2 × Me), 28.6 (2 × CH2), 52.4
(OMe), 52.6 (OMe), 123.6 (d, ³
J
CF = 4.4
Hz, C), 127.7 (2 × CH), 128.2
(2 × CH),
129.0 (d, 4
J
CF = 2.8
Hz, 2 × CH), 129.3 (C), 129.6 (d, 4
J
FC = 1.2 Hz, 2 × CH),
130.2 (d, ²
J
FC = 15.9
Hz, C), 131.5 (C), 131.9 (d, ³
J
FC = 5.5
Hz, CH), 136.6 (d, 4
J
FC = 3.8
Hz, C), 144.7 (d, ²
J
FC = 23.7
Hz, C), 159.1 (d, ¹
J
FC = 256
Hz, CF), 165.4 (CO), 167.9 (d, 4
J
FC = 2.7
Hz, CO). ¹9F NMR (282 MHz, CDCl3): δ = -111.4.
IR (ATR): 3037 (w), 3002 (w), 2961 (m), 2947 (m), 2931 (m), 2671
(w), 1739 (m), 1717 (s), 1613 (w), 1514 (m), 1429 (m), 1396 (m),
1345 (m), 1274 (m), 1247 (m), 1219 (s), 1146 (m), 1118 (m), 1069
(m), 1020 (m), 1003 (m), 968 (m), 848 (m), 835 (m), 794 (m), 683
(m), 575 (m), 531 (m) cm-¹. GC-MS
(70 eV): m/z (%) = 421
(28) [M+ + 1], 420
(100) [M+], 405 (20), 389
(52), 373 (3), 357 (18), 329 (7), 315 (2), 301 (4), 287 (5), 273
(6), 272 (5), 259 (4), 257 (6), 252 (2), 244 (3), 195 (7), 170 (2),
143 (3), 135 (3), 129 (2), 77 (1), 59 (1), 29 (2). HRMS (EI): m/z [M+] calcd
for C26H25O4F: 420.17314: found:
420.173423.
<A NAME="RG34009ST-16">16</A>
Dimethyl 4-Fluoro-5-(3,5-dimethylphenyl)-3-(trifluoro-methylsulfonyloxy)phthalate
(6e): Starting with 3 (152 mg, 0.3
mmol), K3PO4 (95 mg, 0.45 mmol), Pd(PPh3)4 (3 mol%),
3,5-dimethylphenylboronic acid (50 mg, 0.33 mmol) and 1,4-dioxane
(4 mL), 6e was isolated as a colorless
solid (104 mg, 75%); mp 79-80 ˚C. ¹H
NMR (300 MHz, CDCl3): δ = 2.31 (br
s, 6 H, 2 × Me), 3.85 (s, 3 H, OMe), 3.92 (s, 3 H, OMe),
7.02 (s, 1 H, ArH), 7.06 (s, 2 H, ArH), 8.01 (d, 4
J
FH = 6.6 Hz, 1 H,
ArH). ¹³C NMR (62.90 MHz, CDCl3): δ = 20.3 (2 × Me),
52.1 (OMe), 52.3 (OMe), 117.5 (q, ¹
J
CF = 321 Hz, CF3),
124.4 (d, ³
J
FC = 4.4
Hz, C), 125.6 (d, 4
J
FC = 2.75,
2 × CH), 128.8 (C), 130.1 (CH), 130.9 (d, ³
J
FC = 4.6 Hz, CH), 131.1
(d, 4
J = 1.8 Hz,
C), 131.9 (d, ²
J = 13.0
Hz, C), 133.3 (d, ²
J
F,C = 17.0
Hz, C), 137.6 (s, 2 × C), 152.3 (d, ¹
J
FC = 261 Hz, C),
162.7 (d, 4
J
FC = 2.7
Hz, CO). 163.1 (CO). ¹9F NMR (282 MHz, CDCl3): δ = -72.58
(d, J = 13.4 Hz, CF3), -122.34
(q, J = 13.4 Hz, ArF). IR (ATR):
2959 (w), 2921 (w), 1737 (s), 1729 (s), 1620 (w), 1602 (w), 1495
(w), 1428 (s), 1408 (m), 1343 (m), 1275 (s), 1205 (s), 1133 (m),
1006 (m), 945 (m), 854 (m), 813 (s), 757 (m), 731 (m), 598 (s),
532 (s) cm-¹. GC-MS (70 eV): m/z (%) = 466
(8) [M+ + 2], 465
(21) [M+ + 1], 464
(100) [M+], 433 (35), 395
(2), 369 (16), 331 (6), 303 (10), 272 (9), 242 (15), 214 (10), 185
(6), 160 (7), 99 (1), 69 (5), 59 (2). HRMS (ESI, +ve): m/z [M + H]+ calcd for
C19H17F4O7S: 465.06256;
found: 465.06268.
<A NAME="RG34009ST-17">17</A>
General Procedure
for the Synthesis of 7a-c: The reaction was carried
out in a pressure tube. To a dioxane suspension (4 mL) of 3 (228 mg, 0.45 mmol), Pd(PPh3)4 (3
mol%) and Ar¹B(OH)2 (0.5
mmol) was added K3PO4 (143 mg, 0.67 mmol),
and the resultant solution was degassed by bubbling argon through
the solution for 10 min. The mixture was heated at 90 ˚C
under an argon atmosphere for 9 h. The mixture was cooled to 20 ˚C.
Ar²B(OH)2 (0.6 mmol) and K3PO4 (143
mg, 0.67 mmol) were added. The reaction mixtures were heated under
an argon atmosphere for 6 h at 110 ˚C. They were diluted
with H2O and extracted with CH2Cl2 (3 × 25
mL). The combined organic layers were dried (Na2SO4),
filtered and the filtrate was concentrated in vacuo. The residue
was purified by flash chromatography (silica gel, EtOAc-heptanes).
<A NAME="RG34009ST-18">18</A>
Dimethyl 4-Fluoro-5-(2-ethoxyphenyl)-3-(4-ethylphenyl)-phthalate
(7c): Starting with 3 (228 mg, 0.45
mmol), K3PO4 (286 mg, 1.34 mmol), Pd(PPh3)4 (3
mol%), 2-ethoxyphenyl-boronic acid (82 mg, 0.5 mmol), 1,4-dioxane
(4 mL), and
4-ethylphenylboronic acid (85 mg, 0.6 mmol), 7c was isolated as transparent crystals
(114 mg, 58%); mp 104-106 ˚C. ¹H
NMR (300 MHz, CDCl3): δ = 1.15-1.25
(m, 6 H, 2 × Me), 2.61 (q, J = 7.5
Hz, 2 H, CH2), 3.57 (s, 3 H, OMe), 3.78 (s, 3 H, OMe),
3.95 (q, ³
J = 7.0
Hz, 2 H, OCH2), 6.87 (d, J = 8.4
Hz, 1 H, ArH), 6.93 (dt, J = 7.5
Hz, 1 H, ArH), 7.14-7.30 (m, 6 H, ArH), 7.98 (d, 4
J
FH = 6.7 Hz, 1 H,
ArH). ¹³C NMR (62.90 MHz, CDCl3): δ = 14.7
(Me), 15.2 (Me), 28.6 (CH2), 52.3 (OMe), 52.5 (OMe),
64.0 (OCH2), 112.1, 120.5 (2 × CH), 123.7 (C),
127.6 (2 × CH), 127.8 (d, ²
J
FC = 19.0 Hz, C), 128.5
(d, ²
J = 20.7
Hz, C), 129.4, 129.5, 130.1 (3 × CH), 131.0 (d, 4
J = 1.4 Hz, CH), 133.3 (d, ³
J
F,C = 5.6 Hz, CH), 136.8
(d, ³
J
F,C = 4.1
Hz, C), 144.3, 156.3 (2 × C), 159.6 (d, ¹
J
FC = 256 Hz, CF),
165.5 (C=O), 168.1 (d,
4
J = 2.7 Hz, C=O). ¹9F
NMR (282 MHz, CDCl3): δ =
-106.42
(CF). IR (ATR): 2973 (w), 2944 (w), 2929 (w), 2881 (w), 1724 (br
s), 1609 (w), 1580 (w), 1563 (w), 1516 (w), 1497 (m), 1451 (m),
1428 (m), 1390 (m), 1341 (m), 1273 (s), 1249 (s), 1215 (s), 1149
(s), 1123 (m), 1067 (m), 1041 (s), 969 (m), 919 (m), 858 (w), 839
(w), 793 (m), 754 (s), 689 (m), 611 (m), 537 (w) cm-¹.
GC-MS (70 eV): m/z (%) = 438 (5) [M+ + 2],
437 (30) [M+ +1],
436 (100) [M+], 405 (19),
376 (30), 361 (16), 348 (20), 317 (20), 289 (9), 271 (9), 244 (5),
171 (3), 151 (2), 128 (2), 59 (2), 29 (4). HRMS (EI): m/z [M+] calcd
for C26H25FO5: 436.16805; found: 436.168135.